Sikri Vishal's most recent trade in Neogenomics Inc. was a trade of 42,344 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Vishal Sikri | President Advanced Diagnostics | 23 Feb 2024 | 42,344 | 42,344 | - | - | Stock Option (Right to Buy) | ||
| Neogenomics Inc. | Sikri Vishal | President Advanced Diagnostics | 23 Feb 2024 | 25,330 | 25,330 | - | - | Performance Stock Unit | ||
| Neogenomics Inc. | Sikri Vishal | President Advanced Diagnostics | 23 Feb 2024 | 25,329 | 25,329 | - | - | Restricted Stock Unit | ||
| Neogenomics Inc. | Vishal Sikri | President Advanced Diagnostics | 01 Jun 2023 | 21,406 | 127,716 (0%) | 0% | 0 | Common Stock | ||
| Neogenomics Inc. | Vishal Sikri | President Advanced Diagnostics | 11 May 2023 | 39,683 | 39,683 | - | - | Stock Option (Right to Buy) | ||
| Neogenomics Inc. | Vishal Sikri | President Advanced Diagnostics | 11 May 2023 | 21,204 | 21,204 | - | - | Restricted Stock Unit | ||
| Neogenomics Inc. | Vishal Sikri | President Advanced Diagnostics | 11 May 2023 | 21,204 | 21,204 | - | - | Performance Stock Unit | ||
| Neogenomics Inc. | Vishal Sikri | President, Pharma Services | 31 Dec 2022 | 225 | 148,680 (0%) | 0% | 7.0 | 1,584 | Common Stock | |
| Neogenomics Inc. | Vishal Sikri | President and CCO, Inivata | 01 Jun 2022 | 319,112 | 319,112 | - | - | Stock Option (Right to Buy) | ||
| Neogenomics Inc. | Vishal Sikri | President and CCO, Inivata | 01 Jun 2022 | 148,455 | 148,455 (0%) | 0% | 0 | Common Stock |